(NE)-N-[1-(3-butyltellanylphenyl)ethylidene]hydroxylamine
C12H17NOTe — CID 155564910
Data last refreshed: (MolForge compound catalog, from PubChem)
About (NE)-N-[1-(3-butyltellanylphenyl)ethylidene]hydroxylamine
(NE)-N-[1-(3-butyltellanylphenyl)ethylidene]hydroxylamine (PubChem CID 155564910) has the molecular formula C12H17NOTe and a molecular weight of 318.87 g/mol. Its IUPAC name is (NE)-N-[1-(3-butyltellanylphenyl)ethylidene]hydroxylamine.
Molecular Properties
| Compound Name | (NE)-N-[1-(3-butyltellanylphenyl)ethylidene]hydroxylamine |
|---|---|
| PubChem CID | 155564910 |
| Molecular Formula | C12H17NOTe |
| Molecular Weight | 318.87 g/mol |
| Exact Mass | 321.04 |
| IUPAC Name | (NE)-N-[1-(3-butyltellanylphenyl)ethylidene]hydroxylamine |
| SMILES | CCCC[Te]c1cccc(/C(C)=N/O)c1 |
| InChI | InChI=1S/C12H17NOTe/c1-3-4-8-15-12-7-5-6-11(9-12)10(2)13-14/h5-7,9,14H,3-4,8H2,1-2H3/b13-10+ |
| InChIKey | FMQYENYSVAOMNX-JLHYYAGUSA-N |
| XLogP | 2.43 |
| TPSA | 32.59 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 2 |
| Rotatable Bonds | 5 |
| Heavy Atoms | 15 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 318.87 |
| LogP ≤ 5 | 2.43 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 2 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'}, {'alert_name': 'heavy_metal', 'substructure': 'N/A'}, {'alert_name': 'imine_1', 'substructure': 'N/A'}, {'alert_name': 'oxime_1', 'substructure': 'N/A'}, {'alert_name': 'Oxygen-nitrogen_single_bond', 'substructure': 'N/A'} |
|---|
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 155564910 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.